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ABSTRACT
Many viruses utilize programmed –1 ribosomal
frameshifting (–1 PRF) to express additional proteins
or to produce frameshift and non-frameshift protein
products at a fixed stoichiometric ratio. PRF is also
utilized in the expression of a small number of cel-
lular genes. Frameshifting is typically stimulated by
signals contained within the mRNA: a ‘slippery’ se-
quence and a 3′-adjacent RNA structure. Recently, we
showed that −1 PRF in encephalomyocarditis virus
(EMCV) is trans-activated by the viral 2A protein,
leading to a temporal change in PRF efficiency from
0% to 70% during virus infection. Here we analyzed
PRF in the related Theiler’s murine encephalomyeli-
tis virus (TMEV). We show that 2A is also required
for PRF in TMEV and can stimulate PRF to levels as
high as 58% in rabbit reticulocyte cell-free transla-
tions and 81% during virus infection. We also show
that TMEV 2A trans-activates PRF on the EMCV sig-
nal but not vice versa. We present an extensive mu-
tational analysis of the frameshift stimulators (mRNA
signals and 2A protein) analysing activity in in vitro
translation, electrophoretic mobility shift and in vitro
ribosome pausing assays. We also investigate the
PRF mRNA signal with RNA structure probing. Our
results substantially extend previous characteriza-
tion of protein-stimulated PRF.
INTRODUCTION
Programmed ribosomal frameshifting (PRF) is a gene ex-
pression mechanism whereby a proportion of translating ri-
bosomes are stimulated to shift into an alternative reading
frame at a specific site during the decoding of anmRNA (1).
Ribosomes which frameshift produce an alternative pro-
tein product that is N-terminally coincident with the prod-
uct of standard decoding but has a distinct C-terminal re-
gion encoded by either the +1 or the −1 reading frame de-
pending on the type of frameshifting. In viruses, the most
common type of PRF involves −1 nt tandem slippage of
the P- and A-site tRNAs on the mRNA (−1 PRF). Many
viruses use −1 PRF to express the viral polymerase at a
set ratio with other components of the replication complex,
with examples including HIV and other retroviruses, SARS
and other coronaviruses, and many plant RNA viruses (1).
Other viruses use −1 PRF to append an extension domain
onto a proportion of their capsid proteins (e.g. (2,3)), or to
express accessory proteins (e.g. (4,5)). A number of cellu-
lar genes also utilize −1 PRF in their expression, both in
eukaryotes (6,7) and in bacteria (8,9).
In eukaryotes, sites of −1 PRF normally conform to
an X XXY YYZ ‘slippery heptanucleotide’ shift site motif,
whereXXX represents any three identical nucleotides,YYY
represents UUU or AAA, Z represents A, C or U, and un-
derscores separate zero-frame codons. Such sites allow for
P- and A-site anticodon:codon re-pairing following a −1 nt
shift, except potentially at the wobble positions. It should be
noted that the requirement for re-pairing is weaker in the
P-site and a number of exceptions to XXX occur, such as
GGU, GUU, GUC, GAA, GGA and UCC (1). While such
slippery heptanucleotides may allow frameshifting of up to
∼1–2% (for some sequences), in order to achieve a high ef-
ficiency, an extra stimulator is required and this normally
takes the form of a 3′ stable RNA stem–loop or pseudoknot
structure separated from the shift site by a ‘spacer’ region of
5–9 nt. Structures of this type are thought to be located at
the mRNA unwinding site of the ribosome entrance chan-
nel when their stimulatory effect is exerted (10). How the
stimulatory RNAs function to promote −1 PRF is still un-
certain, but accumulating evidence from prokaryotic coun-
terparts indicates that the RNA structure impedes back ro-
tation of the ribosomal small subunit, trapping the ribo-
some in a rotated or hyper-rotated state (11,12). This stalled
state can be resolved either via spontaneous unwinding of
the structure or via a −1 PRF which, by repositioning the
structure within the mRNA entrance channel, is thought to
allow for more efficient unwinding by the ribosome (11).
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Intra-mRNA structures normally lead to a fixed ratio
of frameshifting, ideal for controlling stoichiometry of dif-
ferent components of the replication complex or different
structural proteins. Recent work with porcine respiratory
and reproductive syndrome virus (PRRSV) (family: Ar-
teriviridae) uncovered a new case of PRF where the stim-
ulator involves, not an intra-mRNA structure separated
from the shift site by a 5–9 nt spacer, but instead a pro-
tein binding site (CCCANCUCC) separated from the shift
site by a 10-nt spacer (13–15). The viral protein nsp1 to-
gether with host poly(C) binding proteins (PCBPs) bind
at this site, and the RNA:protein complex positioned at
the leading edge of the ribosome when the decoding cen-
tre is positioned on the shift site is sufficient to stimulate
∼20% efficient−2 PRF and∼7% efficient−1 PRF in virus-
infected cells. Even higher levels (up to∼50%−2 PRF) have
been observed in a recombinant vaccinia virus/T7 poly-
merase expression system. More recently, a completely in-
dependent case of protein-stimulated PRF was identified
in encephalomyocarditis virus (EMCV) (familyPicornaviri-
dae; genus Cardiovirus) where the viral 2A protein binds
to an RNA stem–loop structure separated from the shift
site by a 13-nt spacer (16–18). Ribosome profiling anal-
yses showed that this RNA:protein complex strongly im-
pedes ribosome progress but that this impediment can be
relieved by ribosomes shifting to the −1 reading frame on
the G GUU UUU shift site. Cellular levels of 2A build up
strongly between 4 and 6 h post infection (p.i.), and this cor-
relates with a switch in frameshifting efficiency fromnegligi-
ble levels at 2 and 4 h p.i. to ∼70% at 6 and 8 h p.i., making
this one of the most efficient cases of −1 PRF in a mam-
malian cell system and the only case known to be tempo-
rally modulated.
To date, despite there being hundreds of identified cases
of RNA-structure stimulated PRF, these are the only
two known cases of protein-stimulated PRF. Our previ-
ous work on protein-stimulated PRF in genus Cardiovirus
focused on EMCV. Another well-studied member of this
genus is Theiler’s murine encephalomyelitis virus (TMEV).
The EMCV G GUU UUU frameshift site is conserved in
TMEV, as is the presence of a 3′ stem–loop structure sep-
arated from the shift site by a 13-nt (EMCV) or 14-nt
(TMEV) spacer. In TMEV, however, the stem–loop is more
compact with a 10-nt loop compared to a 21-nt loop (albeit
probably containing internal structure) in EMCV. Further,
the TMEV 2A protein shares only ∼27% aa identity with
the EMCV 2A protein. The late-timepoint PRF efficien-
cies in virus-infected cells have previously been measured
at ∼70% in EMCV (by ribosome profiling) and 74–82% in
TMEV (bymetabolic labelling, whichmay be less accurate).
However, the role of TMEV 2A in the stimulation of PRF
on the TMEV mRNA has not been studied, nor has the
ability of TMEV 2A to cross-activate EMCV PRF, or vice
versa.
Here we investigate protein-stimulated PRF in TMEV.
We show that the TMEV 2A protein stimulates frameshift-
ing on the TMEV mRNA and to a level in rabbit reticulo-
cyte lysate (RRL) cell-free translations considerably higher
than observed previously with the EMCV 2A protein at
the EMCV signal. Thus, TMEV may be a more tractable
in vitro system for future structural and biophysical stud-
ies of 2A action. We show that TMEV 2A stimulates effi-
cient PRF on both EMCV and TMEV mRNAs whereas
EMCV 2A is active only on the cognate EMCV mRNA.
Since 2A is known to interact with the viral L protein, we
tested whether EMCV L has an effect on EMCV PRF but
found none. We also performed an extensive mutational
analysis of protein and RNA stimulators of TMEV PRF
and tested the effects of these mutations in in vitro trans-
lation, electrophoretic mobility shift (EMSA) and in vitro
ribosome pausing assays. The predicted TMEVRNA stem–
loop structure was verified with chemical and enzymatic
structure probing. Finally a 2A mutant defective in RNA
binding was introduced into the virus genome and tested in
the context of infection. Our results confirm the role of 2A
in stimulating PRF at the TMEV signal and substantially
extend previous characterization of cardiovirus frameshift-
ing stimulators.
MATERIALS AND METHODS
Cells, recombinant viruses and plasmids
Cell lines were obtained from the European Collection of
Authenticated Cell Cultures (ECACC) and tested for my-
coplasma by PCR (e-Myco plus Mycoplasma PCR Detec-
tion Kit; iNtRON Biotechnology).
WT andmutant viruses are based on the GDVII strain of
TMEV and were generated from the full-length infectious
clone pSK-GDVII (a kind gift from the Robert Fujinami
lab, University of Utah). The sequence of this clone is iden-
tical toGenBank accession numberNC 001366.1 except for
three nucleotide differences: G2241A (serine to isoleucine in
VP2), A2390G (synonymous change in VP3), and G4437A
(lysine to glutamine in 2B). Nucleotide coordinates herein
are given with respect to NC 001366.1 (19). All constructs
were prepared by standard PCR mutagenesis and recom-
binant DNA techniques and subcloned regions altered by
mutagenesis were verified by DNA sequencing. All viruses
were able to replicate in cell culture. The SS mutations do
not alter the polyprotein amino acid sequence. EMCV se-
quences were obtained from pMC0 (developed by Ann Pal-
menberg, University of Wisconsin-Madison; (20)) which is
identical to GenBank accession number DQ294633.1 in the
region encoding 2A and the −1 PRF signal.
For in vitro frameshifting assays, we cloned a 105-nt se-
quence containing the G GUU UUU shift site flanked by
6 nt upstream and 92 nt downstream, or mutant derivatives,
into the dual luciferase plasmid pDluc at the XhoI/BglII
sites (21). The sequence was inserted between the Renilla
and firefly luciferase genes so that firefly luciferase expres-
sion is dependent on −1 PRF. For the in vitro frameshift-
ing assays with additional 3′ sequence added, NC 001366
nucleotides 4230–4436 (14 nt 5′ + G GUU UUU shift site
+ 186 nt 3′) followed by nucleotides 7500–8101 (last 480
nt of polyprotein ORF + entire 122-nt 3′ UTR) followed
by 21 nt of poly(A) were cloned into vector pEGFP C1 at
the XhoI/BamHI sites to generate pEGFP C1-TGF. In this
construct, the TMEV-encoded sequence is fused to the C-
terminus of eGFP and the non-frameshift product also in-
cludes 160 amino acids corresponding to the C-terminus of
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same except that the region comprising nucleotides 7500–
8101 and the poly(A) tail was omitted.
For ribosomal pausing analysis, the EMCV or TMEV
shift site flanked by 6 nt upstream and 86 nt down-
stream, or mutant derivatives, were cloned into pPS0 at
theXhoI/PvuII sites (22) to generate pPS-TMEV-WT, pPS-
TMEV-SS and pPS-EMCV-SS. For the expression of re-
combinant 2A or L in Escherichia coli, the 2A or L cod-
ing sequences were amplified from pMC0 (EMCV) or
pSK-GDVII (TMEV) and cloned into pGEX-6P-2 (GE
Healthcare) at the BamHI/XhoI sites. The expressed pro-
teins, following removal of the GST moiety by PreScis-
sion Protease (a kind gift from Stephen Graham, Uni-
versity of Cambridge), have an additional five (GPLGS-
) vector-derived residues at the N-terminus. Further, our
early versions of EMCV 2A and TMEV 2A have a
vector-derived C-terminal extension (-NSRVDSSGRIVTD
in EMCV and -EFPGRLERPHRD in TMEV). All TMEV
2A mutants M1, M2, M3 (a.k.a. 2A-mut) and M4 have the
C-terminal extension. All EMSAs use the C-terminally ex-
tended TMEV and EMCV 2As except where indicated oth-
erwise in Figure 8C and D. Elsewhere (i.e. in vitro paus-
ing and frameshifting assays) the WT EMCV and TMEV
2As have the authentic C-terminus, except where WT 2A
is compared with mutants M1–M4 (Figure 7) where the C-
terminally extended WT 2A was used for a rigorous com-
parison.
In vitro transcription and generation of recombinant virus
RNA was transcribed using the Megascript T7 kit (Am-
bion) from BamHI-linearized plasmids. Reactions were
phenol/chloroform extracted, RNA desalted by centrifuga-
tion through a NucAway Spin Column (Ambion) and con-
centrated by ethanol precipitation. Purified RNA was used
to transfect 35-mm dishes of BHK-21 cells using 1.2 g
RNA and 4 l DMRIE-C reagent according to the man-
ufacturer’s instructions. Transfected cells were cultured in
Dulbecco’s modified Eagle’s medium (DMEM) with high
glucose and 1% fetal bovine serum (FBS) for 1 to 5 d de-
pending upon how rapidly cytopathic effect (CPE) devel-
oped. Cultures were subjected to three rounds of freeze-
thawing, cell debris removed by centrifugation for 5 min at
4000 g and the supernatant stored in aliquots at −80◦C.
Plaque assays
BHK-21 cells at 90% confluence in 6-well plates were
infected with serial dilutions of virus stocks. Cells were
washed with serum-free medium, overlaid with virus in-
noculum and incubated for 1 h at 37◦C. Innocula were re-
moved and replaced with 1.5% low melting point agarose
(Invitrogen) containing DMEM containing 2% FBS. After
40 h incubation at 37◦C, cells were fixed with formal saline
and stained with 0.1% toluidine blue.
Metabolic labelling and calculation of PRF efficiencies
BHK-21 cells were infected at a multiplicity of infection
(MOI) of ∼5 in a volume of 150 l in 24-well plates. Af-
ter 1 h the inoculum was replaced with 1 ml DMEM con-
taining 2% FBS. At 7 h p.i., cells were incubated for 1 h
in methionine- and serum-free DMEM, and radiolabelled
from 8 to 9 h p.i. with [35S] methionine at 100 Ci/ml
(∼1100 Ci/mmol) in methionine-free medium. Cells were
scraped into the medium, pelleted at 13 000 g for 1 min,
washed twice by resuspension in 1ml of ice-cold phosphate-
buffered saline (PBS) and pelleted for 2 min at 13 000 g. Cell
pellets were lysed in 35 l 4× SDS-PAGE sample buffer
and boiled for 5 min before analysis by 12% SDS-PAGE.
Dried gels were exposed to X-ray films or to phosphorim-
ager storage screens. Image analysis was carried out using
ImageQuantTL 7.0, and the radioactivity in virus-specific
products quantified.
The intensity for each WT virus product was measured,
normalized by methionine content, and then by the mean
value for VP3 and VP1 to control for lane loading. Next, to
factor out differences in protein turnover besides unquan-
tified processing intermediates, for each biological replicate
the WT and 2A-mut values for VP3, VP1, 2B, 3C and 3D
were normalized by corresponding values for SS mutant
virus. Then the normalized values for 2B, 3C and 3D (i.e.
products encoded downstream of the frameshift site) were
averaged and divided by the average of the values for VP3
and VP1 (i.e. products encoded upstream of the frameshift
site). This gives an estimate of the fraction of ribosomes that
avoid a−1 PRF (Figure 9D).Oneminus this value estimates
the PRF efficiency.
Structure probing
Short, 33P-labelled RNAs (105 nt) containing the TMEV
PRF region (shift site plus 29 nt upstream and 69 nt down-
stream) were prepared by T7 transcription of a PCR prod-
uct generated using primers flanking the PRF region, with
the 5′ primer containing the T7 RNA polymerase promoter
sequence. Structure mapping, using 10 mCi/ml [ -33P]ATP
(PerkinElmer), was performed using a 5′-end-labelling pro-
cedure as described previously (23). All probing reactions
were performed in a final volume of 50 l containing ∼20
000 cpm 5′ [33P] end-labelled transcript, 2 mM MgCl2, 10
g pig liver rRNA, and the relevant enzymatic or chemical
probe. Products were analyzed on a 10% acrylamide/7M
urea gel.
Protein expression and purification
N-terminally glutathione-S-transferase (GST) tagged pro-
teins were purified from E. coli BL21/DE3/pLysS cells.
Overnight cultures inoculated from a single colony were
used to inoculate expression cultureswhichwere then grown
at 37◦C to an OD600 of 0.6. Protein expression was induced
by addition of isopropyl -D-1-thiogalactopyranoside (to
0.1 mM) and continued for overnight at 22◦C after which
cells were pelleted and resuspended in lysis buffer (1.4 mM
-mercaptoethanol, 0.5 mM MgCl2, 0.05% Tween 20, 20
mM Tris pH 7.5, 150 mM NaCl, DNase 1 U/ml and pro-
tease inhibitor 1 U/ml). Cell lysates were prepared by son-
ication (30 min on ice), and cleared by centrifugation (39
000 g, 4◦C, 30min). Proteins were purified using glutathione
agarose resin (GE Healthcare) according to standard pro-
cedures (24), then dialysed against 50 mM Tris, pH 7.5, 100
mMKCl, 1 mM dithiothreitol (DTT), 0.05 mM ethylenedi-
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by Bradford assay (ThermoFisher Scientific), and stored at
−80◦C until required.
Electrophoretic mobility shift assay
Short, 32P-labelled template RNAs containing the TMEV
(59 nt) or EMCV (64 nt) PRF region (with slippery se-
quence precisely at the 5′ end) were prepared by T7 tran-
scription of a PCR product generated using primers flank-
ing the PRF region, with the 5′ primer containing the T7
polymerase promoter sequence. Radiolabelled RNAs were
mixed with test proteins in 10 l reactions in EMSA buffer
(10 mM HEPES pH 7.6, 150 mM KCl, 2 mM MgCl2, 1
mMDTT, 0.5mMadenosine triphosphate, 5% glycerol, 100
g/ml porcine tRNA, 10 U RNase inhibitor ml−1). Test
proteins were diluted in dilution buffer (DB) (5 mMTris pH
7.5, 100 mM KCl, 1 mM DTT, 0.05 mM EDTA, 5% glyc-
erol). For competition experiments, unlabelled competitor
RNA was incubated with WT 32P-labelled RNA (10 nM)
and 2A (0.7 M). Reactions were incubated at 30◦C for 10
min before promptly loading the mix onto non-denaturing,
4% acrylamide gels (acrylamide:bisacrylamide ratio 10:1).
Gels were run at 175 V at room temperature until free and
bound RNA species were resolved, then fixed for 15 min in
10% acetic acid, 10%methanol, dried and exposed to X-ray
film and phosphorimager screen.
In vitro translation
Frameshift plasmids based on pDluc were linearized with
FspI and capped run-off transcripts generated using T7
RNA polymerase as described previously (25). TGF and
TG5 RNAs were prepared by T7 transcription of PCR
products generated using a 5′ primer containing the T7
polymerase promoter sequence upstream of the AUG of
eGFP and appropriate 3′ primer sequences for TGF and
TG5. Messenger RNAs were translated in nuclease-treated
rabbit reticulocyte lysate (RRL) or wheat germ (WG) ex-
tracts (Promega) programmed with ∼50 g/ml template
mRNA. Typical reactions were of 10 l volume and com-
posed of 90% (v/v) RRL, 20 M amino acids (lacking me-
thionine) and 0.2 MBq [35S]-methionine. Reactions were
incubated for 1 h at 30◦C and stopped by the addition
of an equal volume of 100 g/ml RNase A in 10 mM
EDTA, followed by incubation at room temperature for
20 min. Proteins were resolved by 12% SDS-PAGE and
dried gels were exposed to X-ray film or to a Cyclone Plus
Storage Phosphor Screen (PerkinElmer). The screen was
scanned using a Typhoon FLA 7000 (GE Healthcare) in
storage phosphor autoradiography mode and bands were
quantified using ImageQuant™TL software (GE Health-
care). PRF efficiencies were calculated as [IFS1/MetFS1]
/ [IS/MetS + IFS1/MetFS1], where the number of me-
thionines in the stop and −1 frameshift products are de-
noted by MetS and MetFS1 respectively, and the densit-
ometry values for the same products are denoted by IS
and IFS1, respectively. In the cases where both −1 and −2
frameshift products were measurable, PRF efficiencies were
calculated as [IFS1/MetFS1]/[IS/MetS + IFS1/MetFS1
+ IFS2/MetFS2] (for −1 PRF) and [IFS2/MetFS2] /
[IS/MetS + IFS1/MetFS1 + IFS2/MetFS2] (for −2 PRF).
Frameshifting assays were performed at least three times. A
statistical analysis of a representative dataset (from Figure
7) is provided in the Supplementary Information.
Ribosome pausing assays
WG in vitro translation reactions (30l) were supplemented
with 1 M of TMEV 2A, TMEV 2A-mut, EMCV 2A, or
dialysis buffer, and programmedwithmRNAs derived from
AvaII-cut pPS-TMEV-WT, pPS-TMEV-SS or pPS-EMCV-
SS. Reactions were incubated at 18◦C for 5 min prior to the
addition of edeine to 5 M final concentration. Aliquots
(1.5 l) were subsequently withdrawn at set intervals, mixed
with an equal volume of 100 g/ml RNase A in 10 mM
EDTA, and placed on ice. At the end of the time-course,
products were resolved by 12% SDS-PAGE. The expected
size of the ribosomal pause product was marked by trans-
lating a control mRNA produced from XhoI-cleaved pPS0.
RESULTS
TMEV 2A trans-activates PRF
Knowing already that EMCV 2A trans-activates PRF on
the EMCV frameshift sequence, we first tested whether
TMEV 2A trans-activates PRF on the TMEV frameshift
sequence. We titrated recombinant TMEV 2A protein into
a wheat germ extract (WG) cell-free translation system pro-
grammedwith a dual luciferase-based reportermRNA con-
taining the TMEV PRF signal. Following previous work
(16), we engineered a U to C change in the loop of the stim-
ulatory RNA to remove the −1 frame UAA stop codon,
so that ribosomes which frameshift read into the down-
stream reporter gene (Figure 1A). Increasing amounts of
2A led to a general inhibition of cap-dependent translation,
as reported previously for EMCV 2A (Figure 1B) (26,27).
When the reporter was translated in the absence of 2A, only
∼1% PRF was observed (Figure 1B, lane DB). However in
the presence of 2A, efficient PRF was observed, to a level
of ∼20% with increasing amounts of 2A (Figure 1B and
C). Similar results were observed in RRL, except that the
PRF efficiency plateaued at a higher level (∼58%; Figure
1D and E). As a control, we confirmed that inactivation
of the slippery sequence (G GUU UUU to A GUG UUU
mutation; SSmutant) reduced frameshifting to background
levels in both WG and RRL (Figure 2A). To test whether
2A stimulation was specific to the cardiovirus PRF signal,
reporter mRNAs containing the human immunodeficiency
virus 1 (HIV; family Retroviridae) or infectious bronchi-
tis virus (IBV; family Coronaviridae) frameshift signals (28)
were translated in WG or RRL with or without recombi-
nant TMEV 2A protein. For these signals, addition of 2A
had no stimulatory effect on PRF efficiency (Figure 2B).
PRF in TMEV is not modulated by more distal conserved 3′
sequences
Previously, in the context of a reporter construct, we tested
the contribution to PRF of mRNA sequences immediately
3′ proximal to the slippery sequence (92 nt 3′ in (16) for
TMEV and up to 125 nt 3′ in (17) for EMCV). However,
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Figure 1. Effect of increasing concentrations of 2A on PRF efficiency. (A) Mutations introduced into the TMEV PRF signal in reporter plasmid pDluc.
Nucleotide coordinates refer to the TMEV genome. All constructs (including WT) contain a U to C mutation in the loop to remove the −1 frame stop
codon UAA (red). (B–E) RNAs containing the TMEV PRF signal were translated in WG (B) or RRL (D) in the presence of increasing concentrations of
2A, or 2A dialysis buffer (DB). Products generated by ribosomes that do not frameshift (stop) or that enter the −1 reading frame (−1 FS) are indicated.
Frameshifting efficiencies estimated from densitometry are indicated above lanes. Markers are in lane 1. The PRF efficiencies are shown in (C) and (E).
sequence elements, as occurs in luteoviruses where −1 PRF
is stimulated by a 3′-proximal extended stem–loop structure
which forms a kissing interaction with a second stem–loop
positioned nearly 4 kb downstream (29).
To test for potential additional signals, we generated
a new eGFP-based reporter mRNA (TGF; ‘TMEV GFP
full’) containing the TMEV shift site (G GUU UUU) pre-
ceded by 14 nt and followed by 186 nt of TMEV sequence,
fused to the last 480 nt of the TMEV polyprotein ORF, the
entire TMEV 3′ UTR and 21 nt of poly(A) (Figure 2C).
We also generated another reporter mRNA (TG5; ‘TMEV
GFP 5′’) which was similar except that the 480 nt + 3′ UTR
+ poly(A) region was omitted. Our rationale for including
these sequences was that (a) 3′ UTRs often contain regu-
latory elements, (b) our earlier analysis of synonymous site
conservation in an alignment of TMEV-related cardiovirus
sequences revealed conserved overlapping elements (po-
tentially RNA signals) in the 3′ region of the polyprotein
ORF (Figure 1B of (17)), and (c) although this analysis
also suggested that there were no additional conserved el-
ements 3′-proximal to the shift site other than what was
already included in our original reporter construct above
(containing the shift site and 92 nt of 3′-adjacent sequence)
we reasoned that including additional TMEV-derived 3′-
proximal sequence might reduce the potential for spurious
base-pairing interactions between the 3′ stem–loop and ei-
ther vector sequence in the original construct or the TMEV
far 3′-sequences in the new construct, which might impact
PRF efficiency.
Translation of these reporter mRNAs in RRL showed
that both of the extended constructs permitted similar lev-
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Figure 2. 2A stimulation of PRF. (A) RNAs containing the TMEV PRF signal were translated in RRL (left) or WG (right) with 1.8 M recombinant 2A
(lanes 3–4) or with dialysis buffer (DB). SS indicates a shift site mutant. Products generated by ribosomes that do not frameshift (stop) or that enter the
−1 reading frame (−1 FS) are indicated. Markers are in lane 1. (B) RNAs containing the IBV or HIV PRF signals were translated in WG or RRL with or
without 1.8 M recombinant TMEV 2A protein. IFC indicates in-frame controls showing the position at which the frameshift products migrate. Markers
are in the middle lane. (C) Schematic of eGFP-based constructs TGF and TG5. TGF (‘TMEV GFP full’) contains the TMEV shift site (G GUU UUU)
preceded by 14 nt 5′ and followed by 186 nt 3′, fused to the last 480 nt of the TMEV polyprotein ORF, the entire TMEV 3′ UTR and 21 nt of poly(A). TG5
(‘TMEV GFP 5′’) is similar but lacks the 480 nt + 3′ UTR + poly(A) region. (D) TGF and TG5 RNAs were translated in RRL with 1.8 M recombinant
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61% for TG5) indicating that neither the conserved elements
within the last 480 nt of the TMEV polyprotein ORF nor
the TMEV 3′ UTR play a role in PRF stimulation (Figure
2D). These values were also similar to those observed above
(∼58%) for mRNAs with only 92 nt instead of 186 nt of
TMEV-derived sequence 3′-adjacent to the shift site.
A CCC triplet in a 3′ stem–loop is essential for PRF
In EMCV, TMEV and related cardioviruses, there is a con-
served predicted 3′ RNA stem–loop structure separated
from the shift site by a 13–14 nt spacer (Supplementary
Figure S3A of (18)). A completely conserved CCC triplet
in the loop is important for 2A binding in EMCV (18).
The EMCV stem–loop structure is supported by enzymatic
and chemical structure probing, and a mutational analy-
sis has shown it to be critical for PRF stimulation (18,30).
To provide support for the predicted stem–loop structure
in TMEV we performed chemical and enzymatic structure
probing (Figure 3). Short, 33P-labelled RNAs (105 nt) con-
taining the TMEV PRF region (shift site plus 29 nt up-
stream and 69 nt downstream) were treated with chemical
(imidazole, lead acetate; which show specificity for single-
stranded regions) or enzymatic (RNase T1; cuts single-
standed RNA after G residues) probes. The cleavage pat-
tern of the RNA was generally consistent with the pro-
posed stem–loop structure, although the upper portion of
the 3′ arm of the proposed duplex stem was accessible to
the single-stranded chemical probes. Single-stranded probe
cleavage was especially evident in the slippery sequence and
the A-triplet in the loop region.
Previously (before the discovery of the role of 2A in car-
diovirus PRF) we analysed a trio of TMEV stem–loop mu-
tants in the context of a dual luciferase reporter construct
transfected into BHK-21 cells which were subsequently in-
fected with TMEV (16). In these mutants we altered the 5′
part or the 3′ part of the stem to disrupt base-pairing, or
altered both 5′ and 3′ parts together to restore the predicted
duplex but with altered base-pairings at the three basal po-
sitions. However the TMEV loop region was not analysed,
and only a limited analysis has been performed in EMCV
(namely mutations to the CCC triplet; (18)). Therefore we
performed a mutational analysis of the TMEV loop region
(Figure 4A). Mutation of any nucleotide of the CCC triplet
(C50U, C51U, C52U, C50–52A) greatly diminished PRF in
bothWG and RRL (Figure 4B and C). Of these, C52U was
consistently less inhibitory than the other mutations. Ad-
ditional mutations within the CCC triplet (C50A, C51A,
C51G, C52A; tested only in RRL) also nearly completely
abolished PRF (Figure 4D). In contrast, mutating the 5′
adjacent AAA triplet (A47U, A46–48U) that is conserved
in TMEV and related viruses (Saffold, rat theilovirus) and
most, but not all, EMCV isolates (Supplementary Figure
S3a of (18)), had little (A47U) or only modest (A46–48U;
∼1.3-fold reduction in both WG and RRL) effect on PRF.
Similarly, the mutation A42U which separated the apical
base-pair of the duplex had little effect on PRF. Increasing
the loop length by 3 nt (+GAG) had only a modest effect
on PRF (∼1.3- and ∼1.6-fold reduction in WG and RRL,
respectively). We also mutated the first A of the loop to G
(UA/A43G) to, potentially, extend the stem duplex by 1 bp
Figure 3. Structure probing of the 3′ stem–loop. (A) RNA was 5′-end-
labelled with [ -33P] ATP and subjected to limited RNase or chemical
cleavage using structure-specific probes. Sites of cleavage were identified
by comparison with a ladder of bands created by limited alkaline hydrol-
ysis of the RNA (OH−; RNA heated to 100◦C for 95 s [left lane] or 165 s
[right lane]). Enzymatic probing employed RNase T1 (at 1, 10 and 100
U/mL) which preferentially cleaves after G bases in single-stranded re-
gions. Chemical probing was with imidazole (2, 4 and 6 h exposure), or
lead acetate (PbOAc; 10, 20 and 50 mM concentration in reaction), which
show specificity for single-stranded regions. Uniquely cleaved nucleotides
were identified by their absence in untreated control lanes (C). The regions
corresponding to the 5′ and 3′ part of the stem–loop duplex are indicated.
(B) The reactivities of RNase T1 (purple arrowheads) and imidazole (thin
orange arrowheads) are indicated on a schematic of the TMEVPRF signal
showing the evolutionarily conserved stem–loop structure (18). The size of
the symbols is approximately proportional to the intensity of cleavage at
that site.
by base-pairing with the 3′ C of the CCC triplet (the A43G
mutation was performed in the context of the apical base-
pair A·U toU·Amutation, termed ‘UA’; see below). Similar
to the +GAGmutation, this had little effect on PRF inWG
and led to only a ∼1.6-fold reduction in RRL.
PRF is sensitive to spacer length
The importance of spacer length and nucleotide identity in
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Figure 4. Mutational analysis of the loop region. (A)Mutations introduced into the TMEVPRF signal in reporter plasmid pDluc. (B–D) RNAs containing
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insertion or deletion of a single U nucleotide in the EMCV
system (18). To rectify this, wemade a number of spacermu-
tations in the TMEV PRF signal (Figure 5A). Decreasing
or increasing the spacer length by 3 nt (−CCA, +CCA) al-
most abolished PRF (Figure 5B and C). Changing the last
nucleotide of the spacer from C to G (C35G), which is pre-
dicted to add three extra base-pairs to the base of the stem–
loop (5′-UGG-3′ basepairing with 5′-CCA-3′), had little ef-
fect on PRF in WG and led to only a ∼1.5-fold reduction
in RRL.
Single nucleotide insertions or deletions within the
TMEV PRF region are problematic in that they alter the
register to bring +1 frame stop codons (UAA and UAG)
within the stem–loop into the −1 or 0 frame. To facilitate
this analysis, we removed the stop codons by flipping the
apical base-pair of the stem from A·U to U·A, a variation
which is naturally present in rat theilovirus (e.g. GenBank
accession EU542581; see also Supplementary Figure S3A
of (18)). This mutation (termed ‘UA’) alone had little ef-
fect on PRF (Figure 5B and C; lane 6). Changes in read-
ing frame as a result of spacer mutations were further com-
pensated by additional single-nucleotide insertions or dele-
tions downstream of the stem–loop so that the 0,−1 and−2
frame products would migrate at approximately the same
positions for all mutants. In the context of theUAmutation,
increasing the spacer length by 1 nucleotide (UA/+C28) re-
duced −1 PRF 3–5 fold. In RRL, decreasing the spacer by
1 nt (UA/−A29) reduced −1 PRF 4-fold (12%, cf. 48% for
UA alone) but also led to a high levels of −2 PRF (16%)
(Figure 5C). The appearance of a−2 PRFproduct is consis-
tent with previous observations of the effect of spacer length
mutations in RNA-structure stimulated PRF, where there
is potential for (at least) A-site codon:anticodon re-pairing
in the −2 frame (31). In contrast, in WG, decreasing the
spacer length by a single nucleotide (UA/−A29) had no ef-
fect on −1 PRF (16%, cf. 16% for UA alone) and did not
lead to noticeable levels of −2 PRF (Figure 5B). Such dif-
ferences between the in vitro translation systems may be a
consequence of the slightly smaller footprint of plant ribo-
somes (32,33). We made additional single-nucleotide dele-
tions, UA/−G24, UA/−C25 and UA/−A27. Similar to the
UA/−A29 mutation, these had only a small to modest ef-
fect on PRF in WG (Figure 5D) but resulted in a 4–5 fold
reduction in −1 PRF and high levels of −2 PRF in RRL
(Figure 5E). Interestingly, theUA/−G24mutant had a sub-
stantially higher level of −2 PRF than, for example, the
UA/−A29 mutant (41% compared to 18%). It is not clear
why this would be the case, but it may be related to effects
on chain length from the base composition of the remain-
ing spacer. The UU UUU section of the TMEV shift site
is compatible with A-site re-pairing following a −2 nt shift
but the pentanucleotide CG GUU does not allow obvious
P-site re-pairing. We wondered whether the presence of a
5′ pyrimidine (C) might inhibit −2 PRF occurring on the
wildtype (WT) PRF signal. Notably, −2 PRF in PRRSV
(see Introduction) occurs on an RG GUU UUU shift site
(R = purine). However when we mutated the 5′ C to G in
the TMEV PRF signal (C14G) we did not see appreciable
levels of −2 PRF for the WT spacer length (Figure 5B and
C).
TMEV 2A trans-activates EMCV PRF but not vice versa
The TMEV and EMCV 2A proteins are highly divergent
(∼27% aa identity). Moreover, although both stem–loops
contain the CCC triplet, the loop regions are otherwise
quite different in sequence and in size (21 nt in EMCV, 10
nt in TMEV). Thus we wondered whether the TMEV 2A
protein would be able to trans-activate PRF on the EMCV
PRF signal and/or vice versa. RNAs containing the EMCV
or TMEV WT PRF signals were translated in RRL in the
presence of EMCV or TMEV 2A (Figure 6A). Previously,
EMCV 2A was found to stimulate PRF to levels of ∼14–
17% at the EMCV PRF signal in RRL and this level was re-
capitulated here (17%, lane 2). TMEV 2A was able to stim-
ulate similar levels of PRF at the EMCV PRF signal (16%,
lane 1). On the other hand, whereas TMEV 2A stimulated
efficient PRF at the TMEV PRF signal (53%, lane 6), stim-
ulation by EMCV 2A was only slightly above background
(1.2%, lane 7). Thus TMEV 2A can efficiently trans-activate
PRF at the EMCV PRF signal, but not vice versa.
The viral L protein has no effect on PRF
The viral L protein, encoded at the very N-terminus of the
polyprotein is acidic and known to functionally interact
with the basic 2A protein during virus infection (34). How-
ever, whether L has any effect on PRF has not been inves-
tigated. We expressed and purified recombinant EMCV L
protein and titrated increasing amounts into WG or RRL
cell-free translations programmed with reporter mRNAs
containing the WT EMCV PRF signal, with or without
added recombinant EMCV or TMEV 2A (Figure 6B and
C). As before, EMCV 2A or TMEV 2A on their own stim-
ulated PRF to 10–21%. EMCV L on its own was unable to
stimulate PRF. Moreover addition of EMCV L had no ap-
preciable affect on PRF stimulated by TMEV 2A or EMCV
2A in either WG or RRL.
Mutations in TMEV 2A affect PRF efficiency
Realizing that the interaction between 2A and the RNA
stem–loop was likely to involve a basic region on 2A, we
previously identified a run of basic residues that is quite
well conserved across cardiovirus species (KRIRPFR in
the EMCV isolate used in (18), and KGRYRSWKK in
the TMEV isolate used herein). Mutating the first two
arginines to alanines in EMCV (KRIRPFR to KAIAPFR;
R95A/R97A) prevents 2A from binding to the stem–loop
(18). However, the effect of 2Amutations on PRF efficiency
has not been tested in TMEV.
We generated four TMEV 2A mutants targeting dif-
ferent basic residues: M1––K24A/R28A, M2––R45A,
M3––R85A/R87A and M4––K90A/K91A (Figure 7A).
M3 corresponds to the basic site previously mutated in
EMCV 2A. Recombinant mutant 2As were expressed and
purified and tested for PRF stimulatory activity (Figure 7B
and C). Note that, similar to the EMCV 2A and 2A-mut
used in Napthine et al. (18), these mutants contained an
additional 12 vector-derived C-terminal amino acids (see
Methods). In contrast, except where stated otherwise, else-
where in this study the WT TMEV and EMCV 2As had
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Figure 5. Mutational analysis of the spacer region. (A) Mutations introduced into the TMEV PRF signal in reporter plasmid pDluc. (B–E) RNAs con-
taining the TMEV PRF signal were translated in WG (B and D) or RRL (C and E) with 1.8 M recombinant TMEV 2A or with dialysis buffer (DB).
Markers are in lane 1. The right-most lane in (B) and (C) was run on the same gel but a single intervening lane has been excised, as indicated by the vertical
black line.
with the mutants, the C-terminally extended version of WT
TMEV 2A was used in Figure 7B and C. For M2 and M4,
there was no or only a modest decrease in activity (up to 2-
fold). M1 had a 4-fold decrease in activity. Consistent with
the previous EMCV data, M3 had greatly reduced activity
and was not obviously able to stimulate PRF above back-
ground levels. Hereafter, theM3mutant is referred to as 2A-
mut.
Mutations in 2A or the stem–loop inhibit binding
Mutations in the RNA stem–loop or the 2A protein might
inhibit PRF either by reducing or preventing binding be-
tween 2A and the stem–loop, or by altering the geome-
try or other properties of the 2A:stem–loop complex in a
way that alters their interaction with the ribosome when
the ribosome is positioned on the frameshift site. We used
electrophoretic mobility shift assays (EMSAs) to assess
the effect of selected mutations on RNA:protein binding.
Experiments were performed with recombinant 2A pro-
tein and a 59-nt 32P-labelled RNA containing the TMEV
frameshift signal or a 64-nt 32P-labelled RNA containing
the EMCV frameshift signal. For the EMSA experiments,
the C-terminally extended versions of 2A (seeMaterials and
Methods) were used except where stated otherwise.
When the WT TMEV RNA was incubated with increas-
ing amounts of WT TMEV 2A an RNA:protein complex
could be observed, indicating that TMEV 2A binds the
TMEV PRF signal (Figure 8A). In contrast, TMEV 2A-
mut was unable to bind the TMEV PRF signal (Figure
8A). EMCV 2A bound the TMEV PRF signal only very
weakly (Figure 8A), consistent with its inability to stimu-
late efficient PRF at the TMEV signal (Figure 6A). In the
converse experiment, we found that EMCV 2A efficiently
bound the EMCV PRF signal (Figure 8B), consistent with
previous results (18). Moreover, TMEV 2A also bound the
EMCV PRF signal (Figure 8B), consistent with the abil-
ity of TMEV 2A to efficiently stimulate PRF at the EMCV
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Figure 6. Interchangeability of 2A proteins and lack of activity of L protein in PRF stimulation. (A) RNAs containing the EMCV or TMEV PRF signal
were translated in RRL with 1.8 M recombinant EMCV 2A or TMEV 2A or with dialysis buffer (DB). Markers are in the middle lane. (B, C) RNAs
containing the EMCV PRF signal were translated in WG (B) or RRL (C) with 1.6 M recombinant EMCV 2A or TMEV 2A, and/or with EMCV L in
varying amounts, or with dialysis buffer only (DB). Markers are in the first lane.
To test whether the short C-terminal extension of vector-
derived amino acids on the recombinant 2As affected bind-
ing to the PRF signal, we compared WT and C-terminally
extended EMCV and TMEV 2As in the EMSA analyses
(Figure 8C and D). In both cases, the C-terminally ex-
tended 2A had no obvious defect in its ability to bind
the corresponding PRF signal. Note that, as expected, the
RNA:protein complexes for EMSAs performed with the C-
terminally extended 2As migrated more slowly than those
for EMSAs performed with the 2As that had the authentic
C-terminus.
Next we used EMSA competition assays to assess two of
the TMEV stem–loop mutants. Non-radioactive WT, C50–
52U mutant or A46–48U mutant RNAs were competed
against 32P-labelled WT RNA for 2A binding. Whereas the
WT and A46–48U mutant RNAs were able to efficiently
compete withWTRNA––greatly diminishing radiolabelled
RNA:protein complexes at increasing molar excess––the
C50–52U mutant RNA was unable to compete, indicating
that the CCC sequence is important for 2A binding (Figure
8E).
2A is required for PRF during TMEV infection
Protein production by WT and shift site mutant (SS)
TMEVs has previously been assessed bymetabolic labelling
(16). This study found that, at late timepoints, WT virus
produces much lower quantities of the proteins encoded
downstream of the frameshift site than proteins encoded
upstream of the frameshift site when compared with the
SS mutant virus. Normalization of WT by SS allowed the
PRF efficiency in the natural context of virus infection to
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Figure 7. Analysis of TMEV 2Amutants. (A) Amino acid sequence of the
TMEV 2A protein, with residues that were mutated in M1, M2, M3 and
M4 coloured; the corresponding mutations are shown below. (B, C) RNAs
containing the TMEV PRF signal were translated in WG (B) or RRL (C)
with 1.8 M recombinant TMEV 2A, 2A mutants M1, M2, M3, M4 or
with dialysis buffer (DB). Markers are in the first lane. In this experiment,
WT and all mutant 2As were the C-terminally extended versions.
the stimulatory role of 2A, we repeated this experiment with
the addition of 2A-mut, a virus in which we introduced the
R85A/R87A mutations into 2A.
We found that the 2A-mut virus is viable but, like the SS
mutant virus tested previously, it has a small plaque pheno-
type (Figure 9A). The protein expression of 2A-mut is sim-
ilar to SS and both are very different from WT, with much
more efficient expression of downstream proteins such as
2B, 2C, 3C and 3D relative to upstream proteins such as
VP0, VP3 and VP1 (Figure 9B). The 2A-mut protein mi-
grates a little faster than the WT 2A protein. PRF efficien-
cies were estimated from the ratio of downstream to up-
stream expression normalized by the SSmutant (Figure 9C;
see Materials and Methods), giving values of 81% for WT
virus and −5% for 2A-mut (Figure 9D). (The −5% value il-
lustrates the inherent difficulty in making precise measure-
ments of PRF efficiencies viametabolic labelling.) Thusmu-
tating 2A in the virus context inhibits frameshifting.
Ribosomes pause at a mutated cardiovirus PRF site
Our previous ribosome profiling analysis of EMCV-infected
cells showed extensive ribosome pausing (of order 20 s) on a
mutated shift site A GUG UUU (shift site mutant, SS). In
contrast, a much more modest pause was observed on the
WT shift site G GUU UUU. Greatly enhanced pausing on
a mutated shift site was also apparent in an in vitro pausing
assay using a reporter construct (Figure 10A) containing
the EMCV frameshift sequence translated in the presence
of recombinant EMCV 2A protein. To test whether these
results extend to TMEV, we translated in wheat germ (WG)
a reporter construct containing the WT or SS, TMEV or
EMCV frameshift sequence in the presence of recombinant
TMEVor EMCV2A (authentic C-terminus) or TMEV 2A-
mut (C-terminally extended version). The extent of pausing
was assessed by comparing the levels of a translational in-
termediate corresponding to pausing at the shift site with
that of the full-length polypeptide (and also the frameshift
product, where applicable). Translation was synchronized
by the addition of edeine, a potent inhibitor of initiation, 5
min after the start of the reaction and pausing was moni-
tored over a time course.
Consistent with previous observations for EMCV, we ob-
served a protracted pause at the PRF site when TMEV SS
RNA was translated in the presence of TMEV 2A (Fig-
ure 10B), but a more transient pause for TMEV WT RNA
(Figure 10C). In contrast, no pausing was observed when
either RNA was translated in the presence of TMEV 2A-
mut (Figure 10D and E). We also tested for cross-activation
between EMCV and TMEV, using the shift site mutant
RNAs and the WT 2A proteins. As previously seen, trans-
lation of EMCV SS RNA in the presence of EMCV 2A
leads to a very protracted pause (Figure 10F). TMEV 2A
was also able to induce pausing on EMCV SS RNA (Fig-
ure 10G); however the pausing induced by TMEV 2A on
EMCV SS RNA was much less pronounced than that in-
duced by EMCV 2A. On the other hand, EMCV 2A was
unable to induce pausing on TMEV SSRNA (Figure 10H).
Thus the pausing assays are consistent with the frameshift-
ing assays, where TMEV 2A can stimulate efficient PRF on
EMCVWT RNA but not vice versa (Figure 6A).
DISCUSSION
Wehave shown that, like EMCV,−1 PRF inTMEV is trans-
activated by the viral 2A protein. Previous work showed
that the efficiency of−1 PRF in EMCV increases from neg-
ligible levels at 2 and 4 h p.i. to ∼70% at 6 and 8 h p.i, pre-
sumably as a result of increasing cytoplasmic levels of 2A
(18). Thus −1 PRF in EMCV plays a dual role in (i) al-
lowing late timepoint expression of the 14 kDa 2B* pro-
tein, and (ii) down-regulating enzymatic protein expression
by ∼3-fold at late timepoints. In contrast, the 2B* protein
in TMEV has only 14 aa, and currently there is no evi-
dence that the peptide is functional (16). Thus, −1 PRF in
TMEV may play the singular role of down-regulating en-
zymatic protein expression at late timepoints. Metabolic la-
belling indicates that the down-regulation in TMEV may
be ∼5-fold––even stronger than in EMCV. As discussed
previously, this provides the virus with an elegant solu-
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Figure 8. EMSA analysis of cardiovirus 2A RNA binding activity. (A) 32P-labelled RNA containing the WT TMEV PRF signal was incubated with
increasing amounts of TMEV 2A, TMEV 2A-mut, or EMCV 2A and subjected to EMSA on 4% non-denaturing acrylamide gels. (B) 32P-labelled RNA
containing the WT EMCV PRF signal was incubated with increasing amounts of EMCV 2A or TMEV 2A. (C) 32P-labelled RNA containing the WT
EMCVPRF signal was incubated with increasing amounts of EMCV 2A (WT) or the C-terminally extended version of EMCV 2A (C-terminus +). (D) 32P-
labelled RNA containing the WT TMEV PRF signal was incubated with increasing amounts of TMEV 2A (WT) or the C-terminally extended version of
TMEV 2A (C-terminus +). (E) Unlabelled competitor RNA containing the WT, C50–52U mutant or A46–48U mutant TMEV PRF signal was incubated
with 32P-labelled RNA containing the WT TMEV PRF signal, and TMEV 2A (0.7 M), and analyzed by EMSA. In (A, B, E), WT and all mutant 2As
were the C-terminally extended versions (see Methods). In (A–D), numbers below lanes show fold molar excess of 2A with respect to RNA (10 nM). In
(E), numbers below lanes show fold molar excess of competitor RNA with respect to 32P-labelled WT RNA (10 nM). In lanes BSB, DB and H2O, RNA
was incubated alone with band-shift buffer, protein dilution buffer or water, respectively.
while favouring structural protein synthesis at late time-
points (18).
Cardiovirus 2A is a multifunctional protein which has
no homologue among other picornaviruses. The positively
charged region, which is essential for binding to the stem–
loop, also doubles as a nuclear localization signal (26,27).
Early in infection, 2A is targeted to the nucleus and nucle-
olus (26). 2A also binds the virus L protein and is thought
to shuttle it to the nucleus, where L directs hyperphospho-
rylation of nuclear pore proteins resulting in inhibition of
active nucleocytoplasmic trafficking (34–36). At later time-
points, 2A accumulates in the cytoplasm where it exhibits
a diffuse distribution (26). 2A also plays a role in shutoff
of cap-dependent translation although the mechanism re-
mains elusive (26,27). A portion of 2A also associates with
cytoplasmic 40S but not 80S ribosomes (41). More than 40
years ago, 2A was shown to exhibit non-specific RNA bind-
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Figure 9. Mutating 2A inhibits frameshifting in TMEV. (A) Plaque morphology ofWT, SS and 2A-mut viruses on BHK-21 cells. (B) Metabolic labelling of
BHK-21 cells mock-infected or infected with WT, SS or 2A-mut viruses. Positions of TMEV proteins are indicated. (C) Schematic of the TMEV genome.
UTRs are indicated in black and CDSs in pale blue. The lengthy 5′ UTR contains an IRES that directs translation of the polyprotein ORF (L-VP0-
VP3-VP1-2A-2B-2C-3A-3B-3C-3D), its frameshift truncation (L-VP0-VP3-VP1-2A-2B*), and the overlapping L* ORF. The tiny 2B* protein shares its
N-terminal 6 aa with 2B, whereas its C-terminal 8 aa are encoded in the −1 reading frame. (D) Ratio of band intensities between WT and SS, or 2A-mut
and SS viruses.
specificity for the cardiovirus PRF stem–loop with a CCC
loop triplet being a key part of the recognition motif.
Our targeted 2A mutation that prevented binding of 2A
to the stem–loop resulted in a protein expression pattern
in the context of virus infection similar to the SS mutant
(Figure 9B). Specifically, at late timepoints the replication
proteins are expressed at a much higher level relative to
the structural proteins for the mutant viruses in compar-
ison to WT virus. With the benefit of hindsight, similar
protein expression patterns can be seen in the literature
for EMCV mutants in which large parts of 2A have been
deleted (e.g. (38,39)). However, deletions in EMCV 2Amay
also lead to an impairment of VP0-VP3-VP1-2A processing
(38,39), which complicates interpretation of these earlier re-
sults. TMEV mutants with deletions in 2A––one involving
just 11 aa encompassing the conserved basic region altered
in ourM3mutant––have been reported and, although virus
protein expression patterns were not shown, both mutant
viruses were found to be viable but attenuated in BHK-21
cells and were avirulent in mice (40).
The higher in vitro−1 PRF levels observed for the TMEV
signal (∼20% in WG, ∼58% in RRL) compared to the
EMCV signal (16–21% inWG, 14–20% in RRL; (18)) could
be due to a more compact stem–loop less vulnerable to dif-
ferences that might affect RNA folding in vitro, or simply
that the TMEV −1 PRF signal naturally induces higher
PRF levels. The large difference between WG (∼20%) and
RRL (∼58%) for the TMEV PRF signal is likely related to
structural differences between plant and animal ribosomes
(e.g. plant ribosomes have a slightly smaller footprint than
mammalian ribosomes) which may affect the geometry of
the interaction between the ribosome and the 2A:stem–loop
complex; though in principle it could also be due to other
host factors (e.g. host proteins) being involved. In contrast,
much smaller differences were seen between WG and RRL
for the EMCV system (16–21% compared to 14–20%; (18)).
The larger size of the EMCV stem–loop and the EMCV
2A protein may be responsible for this different behaviour.
By analogy, in arterivirus protein-stimulated PRF, the ef-
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Figure 10. Ribosomal pausing at cardiovirus frameshift signals. (A) Wild type (WT) and shift site mutant (SS) TMEV and EMCV frameshift sequences
were inserted into reporter plasmid pPS0. (B–H) RNAs derived from AvaII-cut plasmids were translated in WG and, after 5 min, further initiation was
halted by the addition of edeine, and aliquots were removed at various times and analyzed by SDS-PAGE. Lanes M and C show markers and the expected
size of the ribosomal pause product, respectively. Translations were supplemented with 1.8 MTMEV 2A, TMEV 2A-mut, or EMCV 2A as indicated. (B)
TMEV SS RNA + TMEV 2A. (C) TMEV WT RNA + TMEV 2A. (D) TMEV SS RNA + TMEV 2A-mut. (E) TMEV WT RNA + TMEV 2A-mut. (F)
EMCV SS RNA + EMCV 2A. (G) EMCV SS RNA + TMEV 2A. (H) TMEV SS RNA + EMCV 2A. As well as the full-length product and the transient
pausing product, a frameshift product is produced for TMEVWT RNA in the presence of TMEV 2A only.
PCBP1 or PCBP2 is used as the stimulator, and relative ef-
ficiencies also vary between WG and RRL systems (15).
In vitro reconstitution of −1 PRF at the cardiovirus sig-
nal requires solely the addition of 2A, indicating that no
other viral proteins are essential for PRF stimulation. In
particular, the L protein (see above) appears to have no ef-
fect on PRF. The ability to reconstitute PRF inWG, despite
high divergence between plant and animal proteomes, also
suggests that no additional host proteins are involved. In
contrast, arterivirus protein-stimulated PRF can only be re-
constituted in WGwith the addition of both the viral trans-
activator (nsp1) and mammalian PCBP (15). Further, in
previous RiboTrap assays using the EMCV PRF signal and
EMCV infected cell lysates, no other proteins were observed
to co-immunoprecipitate with the stem–loop at levels simi-
lar to 2A (Supplementary Figure S6A of (18)). The reason
for the significantly lower PRF efficiency observed in vitro
(∼20% in WG; ∼58% in RRL) compared to virus infection
(∼81%) remains unknown, but possibilities include incom-
plete activity of the recombinant 2A, effects of more distal
RNA sequences, or differences in translational environment
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These experiments enhance our understanding of the car-
diovirus PRF signal––one of only two currently known
cases of protein-stimulated PRF. The work provides a plat-
form for future biophysical and structural studies, with
the TMEV version of cardiovirus PRF being particularly
amenable to further study due to the higher in vitro PRF
efficiency (56% in RRL) and more compact nature of the
stem–loop when compared to EMCV. Currently there are
no known cellular examples of protein-stimulated PRF;
however the regulatory dimension afforded to PRFby using
a protein stimulator means that such mechanisms have the
potential to play roles in development and homeostasis. An
increased understanding of viral cases may help elucidate
the potential for cellular cases.
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